Livermore, CA, United States of America

Tomas B Hirschfeld, Deceased


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1990-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tomas B Hirschfeld

Introduction

Tomas B Hirschfeld was a notable inventor whose contributions to the field of technology and medicine have left a lasting impact. He was based in Livermore, California, and held two patents during his career. His work primarily focused on the detection of anti-cancer drug levels and the monitoring of elastomeric materials.

Latest Patents

Hirschfeld's latest patents include a method and apparatus for dose critical in-vivo detection of anti-cancer drug levels in blood. This innovative device utilizes a laser-based fiber optic sensor, known as an optrode, to measure the concentration of DNA-binding anti-cancer drugs in biological fluids. The optrode is designed to continuously monitor drug levels in blood, serum, and urine, providing crucial information for cancer treatment. His second patent involves an elastomer degradation sensor using piezoelectric material. This method allows for the monitoring of the degradation of elastomeric materials by measuring changes in elasticity through a forced harmonic oscillator system.

Career Highlights

Throughout his career, Hirschfeld worked with prestigious institutions, including the University of California and the United States of America as represented by the United States. His innovative approaches to medical and material science have contributed significantly to advancements in these fields.

Collaborations

Hirschfeld collaborated with notable colleagues such as Holly H Miller and Dolores U Olness, further enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Tomas B Hirschfeld's inventions have played a vital role in advancing medical technology and material science. His legacy continues to inspire future innovations in these critical areas.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…